Publications
Recent selected publications supported by Schain Research
Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
Schain F et al. Transfus Apher Sci. March 21:103705. 2023.
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
Novitzky-Basso I et al. PLoS One. March 9;18(3). 2023.
Treatment pattern characterization and outcomes in chronic graft versus host disease patients treated with extracorporeal photopheresis in clinical practise in Sweden
Schain F et al. Bone Marrow Transplant 22 March 2022.
Privacy preserving survival prediction
Fedeli S et al. Institue of Electrical and Electronics Engineers (IEEE) Big Data, 13 January 2022.
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT et al. Scand J Urol. June 7:1-8. 2021.
HRU and sickness absence in newly diagnosed multiple myeloma patients who did not undergo HSCT: Trends in Sweden with the changing treatment landscape
Borgsten F et al. Eur J Hematol. 5 May. 2021.
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
Schain F et al. Eur J Health Econ. 1 March. 2021.
Real-world data on autologous stem cell transplantation in older patients with multiple myeloma
Schain F et al. Annals of Hematology. 20 December. 2020.
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M et al. Scand J Urol. 4 April. 2020.
Survival outcomes in myelofibrosis patients treated with ruxolitinib: a population-based cohort study in Sweden and Norway
Schain F et al. European Journal of Haematology, 103(6), 614–619. December. 2019.
Recent selected conference abstracts supported by Schain Research
Characteristics, treatment patterns and predictors of outcomes in treatment-naive acute myeloid leukemia patients judged ineligible for intensive chemotherapy in Sweden
Schain F et al. Myeloma and Leukemia, 1 September 2021.
Healthcare resource utilization and sickness absence in newly diagnosed multiple myeloma patients in Sweden: Trends in a changing treatment landscape
Borgsten F et al. American Society of Hematology. 5 December 2020.
Survival outcomes in patients with colorectal cancer in Sweden – A population based retrospective registry study
Pasquali L et al. Value in Health. 16 November 2020.
Patient characterization and survival outcomes in pediatric chronic graft versus host disease patients: a population-based study in Sweden
Schain F et al. Bone Marrow Transplant. 1 September 2020.
Real-world treatment patterns in patients with castration-resistant prostate cancer
Vigneswaran HT et al. J Clin Oncol. 20 May 2020.
Clinical outcomes and economic burden for bladder cancer patients: an analysis from a Swedish cancer registry
Bellmunt J et al. J Clin Oncol. 1 April 2020.
